ESC CONGRESS 2019

31 August - 04 September 2019, Paris - France

Session Details

Hot Line Session 1
Sun 01 Sep 14:30 - 16:10 European Society of Cardiology - Other Late-Breaking Science, Mobile App - Ask a Question Paris - Main Auditorium
Chairpersons: Barbara CASADEI (Oxford, United Kingdom of Great Britain & Northern Ireland), Stephan ACHENBACH (Erlangen, Germany), Marco ROFFI (Geneva, Switzerland)

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Time
 
FP Nr
 
Title
 
Speakers
 
Related documents
14:302097THEMIS - Main Results of the Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study Deepak BHATT (Newton, United States of America)
14:432098THEMIS-PCI: Ticagrelor in Patients with Diabetes and Stable Coronary Artery Disease with a History of Prior Percutaneous Coronary InterventionPhilippe Gabriel STEG (Paris, France)
14:562099Discussant review - THEMIS/THEMIS-PCIColin BAIGENT (Oxford, United Kingdom of Great Britain & Northern Ireland)
15:002100Questions from the audience and discussion 
15:042101PARAGON-HF - Angiotensin Receptor Neprilysin Inhibition in Heart Failure with Preserved Ejection FractionScott SOLOMON (Boston, United States of America)
15:172102Discussant review - PARAGON-HF.Stuart J CONNOLLY (Hamilton, Canada)
15:212103Questions from the audience and discussion. 
15:252104COMPLETE Revascularization with Multivessel Percutaneous Coronary Intervention in ST-segment Elevation Myocardial InfarctionShamir R MEHTA (Hamilton, Canada)
15:382105Discussant review - COMPLETE.Stefan JAMES (Uppsala, Sweden)
15:422106Questions from the audience and discussion. 
15:46 DAPA HF - The Dapagliflozin And Prevention Of Adverse-outcomes In Heart Failure TrialJohn MCMURRAY (Glasgow, United Kingdom of Great Britain & Northern Ireland)
15:59 Discussant review - DAPA-HF.Marco METRA (Brescia, Italy)